Jump to content

Hang onto your hat: Sclero Forums Upgrade May 14-21, 2017!! The Forums will be offline for up to 4 days, and then will return with an entirely new look and feel.


Roche Gains U.S. Breakthrough Therapy Designation for Actemra Drug.

  • Please log in to reply
No replies to this topic

#1 greypilgrim256


    Senior Bronze Member

  • Members
  • PipPipPip
  • 75 posts
  • Location:New Jersey

Posted 10 June 2015 - 02:44 AM

Just read about this this morning. Is anyone on this? 


Roche Gains US Breakthrough Therapy Designation for Actemra Drug.


The U.S. Food and Drug Administration research showed early treatment with Actemra could prevent irreversible damage to joints in patients with systemic sclerosis and held stave off long-term disability. Dow Jones Business News, 06/10/2015. (Also see Scleroderma Clinical Trials)


This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.